Results 191 to 200 of about 51,949 (245)

Intravenous or Intra-Arterial Thrombolysis?

openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Stroke Mimics and Intravenous Thrombolysis

Annals of Emergency Medicine, 2012
The necessity for rapid administration of intravenous thrombolysis in patients with acute ischemic stroke may lead to treatment of patients with conditions mimicking stroke. We analyze stroke patients treated with intravenous thrombolysis in our center to characterize cases classified as stroke mimics.We identified and reviewed all cases with a ...
Meretoja Atte, Strbian Daniel, Silvennoinen H., Putaala J., Piironen K., Happola O., Liebkind R., Atula Sari, Artto V., Meretoja Atte, Strbian Daniel, Silvennoinen H., Putaala J., Piironen K., Happola O., Liebkind R., Atula Sari, Artto V.   +17 more
openaire   +4 more sources

Cystatin C and intravenous thrombolysis

European Journal of Neurology, 2021
With great interest, we read the recent original article written by Zihan Chang et al1 , which was published in European Journal of Neurology. In this multicenter retrospective case-control study, the authors found that elevated serum Cystatin C may be associated with unfavorable clinical outcomes after intravenous tissue plasminogen activator therapy,
Meidi Peng, Yupei Chen, Guiling Geng
openaire   +2 more sources

Beyond Intravenous Thrombolysis

CNS Spectrums, 2007
ABSTRACTThe National Institute of Neurological Disorders and Stroke trial of recombinant tissue plasminogen activator has been considered a landmark study in the acute treatment of ischemic stroke. Unfortunately, only a small percentage of all ischemic stroke patients presents to the hospital in time to receive the drug.
Kiwon, Lee, Srikanth, Muppidi, Farhan, Siddiq, Carissa, Pineda, David G, Brock, Rodney D, Bell   +5 more
openaire   +2 more sources

Intravenous thrombolysis in Sneddon’s syndrome

Journal of Clinical Neuroscience, 2012
Sneddon's syndrome (SS) is an uncommon disorder, characterized by the association of ischemic stroke and widespread livedo reticularis. The treatment options for SS to prevent stroke recurrence and future disability include antiplatelet therapy, anticoagulation, or immunosuppression.
Jianzhong, Sun, Fanhui, Zhang, Feng, Gao, Jihua, Wang, Magdy, Selim, Min, Lou   +5 more
openaire   +2 more sources

Intravenous thrombolysis for acute stroke

Neurology, 1997
Until recently there was no specific therapy for stroke, but the recent publication of the National Institute of Neurological Disorders and Stroke(NINDS) t-PA for Acute Stroke Trial presents the first effective, specific therapy for stroke.1 In considering whether to apply thrombolysis to any given patient, the physician must consider the factors ...
P D, Lyden, J C, Grotta, S R, Levine, J R, Marler, M R, Frankel, T G, Brott   +5 more
openaire   +2 more sources

Intravenous Thrombolysis in Acute Myocardial Infarction

Chest, 2001
(CHEST 2001; 119:253S‐277S) F ibrinolytic therapy for acute myocardial infarction (MI) has been one of the most potent treatments ever developed for a condition that kills more patients worldwide than any other. This review will focus on approved agents and the randomized trials that have led to their widespread use.
Ohman E., Harrington R., Cannon C., AGNELLI, Giancarlo, Cairns J., Kennedy J.   +5 more
openaire   +3 more sources

Cerebral Perfusion Imaging for Intravenous Thrombolysis Treatment

Topics in Magnetic Resonance Imaging, 2021
Abstract Intravenous thrombolysis is the cornerstone of acute ischemic stroke treatment. However, the benefits of recanalization and reperfusion must be balanced against the risk of intracranial hemorrhage. Time from symptom onset was previously the most important selection tool for identifying patients who would benefit from ...
Diana E, Slawski Md, Gregory W, Albers Md   +1 more
openaire   +2 more sources